Status:
WITHDRAWN
Dino Egg in Neonatal Intensive Care Unit
Lead Sponsor:
Jonathan Slaughter
Conditions:
Premature Birth
Eligibility:
All Genders
32-34 years
Phase:
NA
Brief Summary
Dino EGG mother's voice exposure and multisensory processing in Neonatal Intensive Care Unit infants. This is a 2 phase prospective comparative effectiveness trial of our parents' voice intervention ...
Eligibility Criteria
Inclusion
- Inclusion criteria will be Post Menstrual Age (PMA) 32 0/7-34 6/7.
Exclusion
- Ventilation using an endotracheal tube
- Major congenital malformations
- Family history of genetic hearing loss
- Use of sedatives or seizure medications
- Presence of severe neural injury on neuroimaging (intraventricular hemorrhage grade II or IV, periventricular leukomalacia, cerebellar hemorrhage, ischemic or thrombotic injury)
- Presence of systemic inflammatory conditions (history of necrotizing enterocolitis Bell's stage IIA or above or culture-documented sepsis or meningitis).
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03447405
Start Date
July 1 2019
End Date
January 1 2024
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205